Neha Ghosh is a QC Bioassay Specialist in Emergent Biosolutions, the only FDA licensed anthrax vaccine producer. She joined the company in 2018 where she utilizes her expertise in developing new plans and designing new methods for bioassays used for development and Quality testing of anthrax vaccine. She is also involved in several Scientific writings for communication with FDA. Prior to Emergent, she was R&D Scientist at Trinity Biotech where her major role as a scientist was conducting in-depth studies and evaluating data to develop innovative solutions for improvements of HPLC used for the quantitation of diabetic biomarker (HbA1c). She also worked as Laboratory Manager in King Abdullah University of Science and Technology (KAUST), Saudi Arabia and spearheaded developments and maintenance of Epiginetics lab. Dr. Ghosh received her PhD from Defence Research and Development Establishment (DRDO), India where her major achievement was development of innovative Bioassays for diagnosis of Anthrax.